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Colon cancer patients with a serious
psychiatric disorder present with a more
advanced cancer stage and receive less
adjuvant chemotherapy - A Nationwide
Danish Cohort Study
Linda Kaerlev1,2* , Maria Iachina1,2, Oleg Trosko3†, Niels Qvist4†, Pernille Møller Ljungdalh1,2†
and Bente Mertz Nørgård1,2†
Abstract
Background: Psychiatric patients with colorectal cancer may have delayed diagnosis and be oncologically
undertreated.
Methods: The Danish Colorectal Cancer Group database comprised 25,194 colorectal cancer patients (CRC), (colon
cancer (CC, n = 16,641), rectal cancer (RC, n = 8553)), having an operation in 2007–2013, were alive at least 30 days
after operation, of which 422 have had at least one hospital contact for a serious psychiatric disorder; ICD-10: DF20–
29: primary psychotic disorders, or DF30–39: affective disorders (exposed) in a period of 3650–120 days before the
operation date. Pearson chi-squared test for cancer stage was calculated. Odds Ratio (OR) with 95% confidence
interval (CI) for having had a palliative vs an intended curative aim of the operative treatment for CRC patients
(cohort 1), and for having an oncological treatment for each cancer site CC or RC (cohort 2 and 3) in patients with
and without a psychiatric history was estimated. We adjusted the OR for: age, gender, comorbidity index, cancer
stage, socio-economic position group, and educational level.
Results: A higher cancer stage at the time of operation in patients with psychiatric disorders compared with patients
without such a history was seen and may possibly point towards a delay in the diagnosis or in the treatment of CC in
patients with psychiatric disorders. They also had decreased adjusted OR for having an oncological treatment, OR 0.55,
95% CI (0.40–0.76)), which was not explained by cancer stage. For patients with RC no difference was seen.
Conclusions: Attention for CC patients with pre-existing serious psychiatric disorders is recommended.
Keywords: Colon and rectal cancer, Psychiatric disorders, Psychotic disorders, Mood disorders, Oncological treatment,
Operation
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Background
Although cancer incidence in psychiatric patients is
similar to that in the general population psychiatric
disorders may have a negative impact on the prognosis
of cancer [1–8]. However, psychiatric disorders may
affect the advocating or acceptance of cancer diagnostic
procedures or treatment as suggested for lung cancer
patients [9].
For colorectal cancer (CRC) patients in Denmark, the
treatment with an operation, the neoadjuvant or the
adjuvant chemotherapy is carried out according to
the current national guidelines. Existing significant
co-morbidity may change the clinical decision-making
according to the guidelines although it may compromise
the oncological result [10–12].
We do not know if pre-existing psychiatric disorders
in CRC patients also significantly change the CRC treat-
ment offered to these patients.
The oncological treatment in colon cancer (CC)
patients who has undergone an operation depends on
the TNM-staging (tumor, node, metastasis) of the CRC
and is mainly adjuvant (at pathological TNM-staging II
and III), whereas stage IV treatment is considered
palliative. In rectum cancer (RC) patients, neo-adjuvant
radio-chemotherapy is common with the primary aim to
prevent local recurrence after the operation [13–15]. A
number of confounding factors such as cancer stage
at diagnosis, comorbidity, age, gender, and educational
level may be important for the additional treatments
for CRC these patients receive, and must therefore be
taken into account in analyses [8, 16–23]. We aimed
to investigate if pre-existing serious psychiatric disor-
ders affect the cancer stage at the time of operation,
having palliative vs an intended curative aim of the
operative treatment, or having an oncological
treatment in CRC patients.
Methods
The diagnostic process in patients with symptoms of
CRC often starts with examinations and tests performed
by a general practitioner, and if a suspicion of cancer is
present, the person is referred to specialist evaluation
and a colonoscopy at public hospitals in Denmark.
The Danish Colorectal Cancer Group database
The study is based on the nationwide Danish Colorectal
Cancer Group database (DCCG) including incident pa-
tients with CC and RC during 1 January 2007 until 31
December 2013. The DCCG does not register recur-
rences of the cancer after the primary operation. The
database is more than 98% complete for all CRC patients
in Denmark of all ages (approximately two-third CC,
one-third RC) [10]. The database contains detailed data
on the priority or urgency of the operation of the
patients with CRC, and the variable has the categories:
elective operated patients, acute operated patients, and
patients with missing information regarding this issue.
The DCCG has a variable “operative aim”, with the
three categories: intended curative or palliative aim of the
operation, or missing information regarding this issue.
The DCCG also has a categorical variable “Treatment”
based on the decisions made by the multidisciplinary
cancer team (MDT). We selected for the present study
only those patients in the DCCG having had an oper-
ation for CC or RC based on this variable (thus exclud-
ing those patients without having an operation, or
missing information on operation (< 8% of cases), and
after this restriction of the study population the variable
had no missing values. The variable on treatment for all
patients who were operated had the following categories:
whether there was operation only, operation followed by
adjuvant oncological treatments, neoadjuvant onco-
logical treatment followed by an operation or operation
with both neoadjuvant and adjuvant oncological treat-
ments. This information was combined into a new vari-
able: having oncological treatment (yes/no) -in addition
to the operation.
The DCCG contains data on cancer type and on the
clinical and the pathological cancer stage. The clinical
TNM classification, cTNM or just TNM, is based on e.g.
clinical, endoscopic and image diagnostic findings at the
time of diagnosis and is essential in relation to
decision-making on e.g. operation and evaluation of
treatments. The pathological TNM classification, pTNM,
is based on the histopathological examination of the
operative specimen, possibly modified by per- and post-
operative findings, and forms the basis for
decision-making on the postoperative oncological treat-
ment and prognostic evaluation [24]. In the DCCG, the
5th edition of The Union for International Cancer Con-
trol (UICC)'s TNM-cancer staging classification was
used until 2016 (when it was replaced by the 8th edition)
[25–27]. The pathological UICC cancer stage variable
was grouped into stage I-II versus III-IV.
The Civil Registration Number
Persons with a permanent address in Denmark have a
unique 10-digit civil registration number, which includes
information on birthday and gender, dead/alive and
immigration status in The Danish Civil Registration Sys-
tem [28, 29]. We used this number to link the CRC co-
horts in the DCCG with each CRC patient’s hospital
contacts as recorded by the Danish National Patient
Registry [30] for information on the exposure of serious
psychiatric disorders and on comorbidity [31–33], and
public registries developed by Statistics Denmark such
as The Household and Family Statistics (based on The
Danish Civil Registration System) as well as the personal
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income statistics to calculate educational level, and
socio-economic position group [34].
Inclusion criteria for the cancer cohorts
A total of 26,897 patients with an operation for CRC
were retrieved from the DCCG during the 7-year period
1 January 2007 until 31 December 2013. Our study
period ended just before the Danish screening
programme for CRC in the general population aged 50–
74 years was implemented 1 March 2014.
A priori in the study design phase we decided to make
restrictions to the study population. Observations were
excluded if the patients were not operated for the cancer
with a registered date of the operation. To avoid that
perioperative complications had influence on the choice
of treatments, and to ensure that the patients were alive
long enough to be offered an oncological treatment, ob-
servations were excluded if the patients died within the
first 30 days after their operation.
For the analyses of CRC patients having received a pal-
liative vs an intended curative aim of the operative treat-
ment all the CRC patients were included for the analyses
(cohort 1) and split by having a pre-existing psychiatric
disorder (yes/no).
For the analyses of CRC patients having received at
least one oncological treatment in the DCCG before
or after the cancer operation we stratified the ana-
lyses into CC patients only (cohort 2) and RC pa-
tients only (cohort 3).
Pre-existing serious psychiatric disorders according to
The National Patient Registry
Each CRC patient was linked to The National Patient
Registry to collect information on hospital contact for:
ICD-10 DF20–29: Schizophrenia, schizotypal and delu-
sional disorders (primary psychotic disorders), or
ICD-10 DF30–39 mood (affective) disorders as the
primary diagnosis in the time-period from 10 years to
120 days prior to the date of the CRC operation [30]. If
yes, the patients were regarded as exposed, otherwise
not-exposed. Exclusion of psychiatric disorders diag-
nosed up to 120 days before the date of the cancer oper-
ation was done to avoid that natural psychological crisis
reactions as a result of the cancer diagnosis were
misclassified as pre-existing psychiatric disorders.
Measures of the outcomes
The CRC patients (with and without a psychiatric his-
tory) were examined in the DCCG for the cancer
stage at the time of the operation, and for having
received palliative vs an intended curative aim of the
operative treatment, and for receiving at least one
oncological treatment either before or after the cancer
operation [10].
Demographic characteristics, cancer stage and possible
confounders
Using the unique civil registration number, we obtained
the gender and date of birth, and migration and death.
The UICC pathological cancer stage variable was taken
from the DCCG. Information on co-morbidity was ob-
tained from The National Patient Registry merged with
the DCCG, with calculation of a slight modification of
the Charlson Co-morbidity Index by excluding all con-
tacts with CRC prior to the date of the CRC operation
from the comorbidity index score [31–33]. Each of the
19 categories of comorbid diseases was assigned a sever-
ity score between 0 and 6, and the comorbidity index
was calculated as the sum of the scores (possible range
between 0 and 37 for each patient). The predictive value
of the comorbidity index is high [32]. Cancer diagnoses
within 150 days before the date of CRC operation may
be CRC misclassified as other cancers and was not in-
cluded in the comorbidity index. The comorbidity index
was re-coded as a score into a categorical variable (0, 1,
and above 1 point).
The registries developed by Statistics Denmark was
used to calculate socio-economic position, which was
included as quartiles in the analyses (for the main
analyses yearly income below DKK 143,927, DKK from
143,927–178,573, DKK from 178,573-247,677.4, and
above DKK 247,677.4) [34]. Educational level from
Statistic Denmark was included in the analyses as a cat-
egorical variable: 1) elementary school only, 2) upper
secondary education/vocational education and training
3) qualifying educational programmes/vocational
bachelor education/bachelor programmes/masters pro-
grammes/PhD programmes.
Analysis
We compared the CRC patients, who have had a
psychiatric disorder with the CRC patients without a
psychiatric history with respect to demographic char-
acteristics and cancer stage at the time of the oper-
ation with Pearson chi-squared tests. Continuous
variables were compared between the groups with
Students t-test. The date of the operation was the
index date in the study.
Specifically for the descriptive analyses for the patients
with CRC and the analyses for cancer stage, we used all
the patients with CRC and we further stratified the
analyses into the acute operated CRC patients only, and
CRC patients who had undergone an elective operation
only, and excluding those patients with missing informa-
tion regarding this issue.
The distribution of the cancer treatment by
pre-existing psychiatric disorder status was calculated
(provided in Table 3). For the analyses of palliative vs an
intended curative aim of the operative treatment, we
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used all the CRC patients. For the analyses of the onco-
logical treatment outcomes all the CRC patients was
split by anatomical site of the cancer, CC or RC. We
estimated the odds ratio (OR) with 95% confidence
intervals (CIs) for the patients with a psychiatric history
for having received palliative vs an intended curative aim
of the operative treatment, and for having at least one
oncological treatment (before or after the operation) by
logistic regression.
We adjust for each of the possible important con-
founders as described in the CRC literature: gender,
age and the Charlson comorbidity index score, patho-
logical cancer stage (UICC cancer stage I-II versus III
-IV) [24], socio-economic position (four levels), and
educational level (three levels) in the adjusted analysis
model. After each adjustment step we evaluated the
corresponding OR with 95% CI.
We have analyzed the correlation between each of the
possible confounders and between having had a psychi-
atric disorder and the confounding factors.
Finally, sub-analyses were performed with restriction
to primary psychotic disorders only, affective disorders
only, and to elective operated patients or to acute oper-
ated patients only.
Results
Figure 1 shows the selection of all the CRC (cohort 1),
CC and RC only (cohort 2 and 3)) used for the present
study, and the subgroups of elective and the acutely
operated CRC used for the supplementary descriptive
statistic in Table 1. A total of 1703 CRC patients (44 in
the psychiatric diagnosis group, 1659 in the reference
group) died within the first 30 days after operation and
were excluded, leaving a total of 25,194 CRC patients
a CC= colon cancer,  RC= rectal cancer
b Having had an operation for the CC or RC cancer.
c Having had a history of hospital admission for at least one psychiatric diagnosis as the primary diagnosis according to ICD-10-criteria: DF20-29:
primary psychotic disorders, and DF30-39: affective disorders in the time period from 10 years to 120 days prior to the colorectal cancer operation.  
d Intended curative treatment among colon and rectal cancer patients combined regardless of acute or not.
e Oncological treatment= at least one oncological treatment (chemotherapy or radiotherapy), by cancer site. Oncological treatment is mainly given as 
neoadjuvant treatment for rectal cancer before the operation and is mainly given as adjuvant treatment for colon cancer, thus as supplementary 
treatment after the operation.
CC a and RC a alive 30 days after operation b, N=25,194 (Cohort 1)
Number and % with a pre-existing psychiatric disorder c 422 (1.68 %), referents without a psychiatric history 24,772 (98.32 %) 
For the analyses of intention of curative cancer treatment d
RC, N= 8,553 (Cohort 3)
For RC a oncological treatment e analyses
CC a and RC a alive 30 days after operation, 
CC and RC patients with missing information 
on priority or urgency of the operation, 
n=3,206 (12.73 % of total)
CC, N= 16,641 (Cohort 2)
For CC a oncological treatmente analyses
All colon cancer (CC) a and rectal cancer (RC) a patients with an operation b in 2007-2013 in the DCCG database, N=26,897. 
Number and % with at least one psychiatric disorder c 466 (1.73 %), referents without psychiatric disorders c 26,431 (98.27 %) 
CC a and RC a alive 30 days after operation, elective, 
n=19,532 (77.53% of total CC and RC combined).
Number and % with at least one psychiatric disorderc
283 (1.45 %), referents without having a psychiatric 
disorder 19,249 (98.55 %).
CC a and RC a alive 30 days after operation, acute, n=2,456
(9.75 % of total CC and RC combined).
Number and % with at least one psychiatric disorderc 62 
(2.52 %), referents without having a psychiatric disorder 
2,394 (97.48 %).
CC a and RC a not alive 30 days after 
operation, 
n=1,703 (44 in the psychiatric diagnosis 
group, 1,659 in the reference group)
Fig. 1 Selection of colon and rectal cancer patients from the DCCG for the study
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(422 with a pre-existing psychiatric history, and 24,772
in the reference group) alive at least 30 days after their
operation for the study (Fig. 1). The number of CRC
patients increased from 2007 to 2013: in 2007 3147, in
2008 3577, in 2009 3517, in 2010 3596, in 2011 3688, in
2012 3803, to 3866 in 2013. The 422 CRC patients with
at least one serious psychiatric diagnosis in The National
Patient Registry (301 patients with CC, and 121 patients
with RC) had altogether 572 psychiatric diagnoses with
the majority of the diagnoses within DF30–39:
affective disorders (445 (77.8%)), and less than
one-fourth 127 (22.2%) was within DF20–29: primary
psychotic disorders.
For information on priority or urgency of the oper-
ation, the 25,194 patients with CRC was registered as
electively operated patients only (n = 19,532, 77.53%), as
acutely operated CRC patients only (n = 2456, 9.75% of
total CRC), whereas the rest (n = 3206, 12.73% of total
CRC) was registered with missing information regarding
this issue (Table 1).
For information on “operative aim”, the majority of
the CRC patients was registered with having had an
intended curative operation (n = 19,700, 78.19%) and far
fewer had a palliative aim of the operation (n = 2310,
9.17%), and missing values (n = 3184, 12.64%).
Characteristics of the overall group of CRC patients,
(cohort 1) as well as for elective patients only or acutely
operated patients only are given in Table 1.
Information on cancer stage was available for 23,647
patients (n = 390; 92.42% with, and n = 23,257; 93.88%
without a preexisting psychiatric disorder) and missing
for 1547 patients (n = 32; 7.58% with and n = 1515;
6.12% without a preexisting psychiatric disorder).
The CRC patients with a psychiatric disorder differed
statistically significantly from the patients without a psy-
chiatric disorder at the date of the cancer operation by
more women, lower mean age and socio-economic pos-
ition group, higher comorbidity index scale, and cancer
stage at the time of the operation (high cancer stage
53.79 versus 49.25%, p = 0.038), but not by educational
level. Slightly more CRC patients with a psychiatric dis-
order were treated acutely (62/422*100 = 14.7%) com-
pared with CRC patients without a psychiatric history
(2394/24772*100 = 9.7%) (data not shown).
The acute CRC patients in general had a higher cancer
stage than their non-acute registered counterparts (68%/
49%). In a sub-analysis on electively operated CRC pa-
tients only, similar findings were seen except that the
cancer stage no longer differed between patients with
and without a psychiatric history.
Table 2 shows descriptive statistics for the overall
group of CRC patients split by cancer site: CC (cohort 2)
and RC (cohort 3). As for CRC patients in cohort 1,
similar findings were seen for the subgroup of CC
patients including a higher cancer stage (54.49% versus
51.03%, p = 0.03) at the time of the CC operation. For
RC, the patients with a psychiatric history only differed
from those without by lower mean age, lower
socio-economic position group, and more comorbidity.
In Table 3, the crude and adjusted OR for having
undergone at least one oncological treatment for the
CRC, CC, or RC patients with a psychiatric history com-
pared with those without psychiatric disorders is shown.
The OR adjusted for age, gender, comorbidity index
score, cancer stage, socio-economic position, and educa-
tional level is provided in Table 3. For CRC patients with
a psychiatric history compared to those without, no stat-
istical significant differences were seen between these
two groups for having received a palliative vs an
intended curative aim of the operative treatment.
Similar analysis for acute operated patients only, also
showed no significant differences in the percentage of
CRC patients receiving palliative treatment between the
patients with and without a psychiatric history p = 0.797
(data not shown).
For CC patients with a psychiatric history compared
to CC patients without a psychiatric history the adjusted
OR for at least one oncological treatment was OR 0.55,
95% CI (0.40–0.76). The association was present both
before and after adjustment for cancer stage. For the RC
group with a psychiatric history no differences were seen
for having received at least one oncological treatment,
OR = 0.72, 95% CI (0.46–1.11).
In sub-analyses with restriction to primary psychotic
disorders, or to affective disorders only, the results were
still statistically significantly decreased for oncological
treatment of CC. For each of the outcomes we investi-
gated, whether stepwise adjustment for any of the
possible confounding factors: age, gender, Charlson Co-
morbidity Index score, the cancer stage at the time of
operation, socio-economic position, and educational
level had statistically significantly influenced the OR of
psychiatric history. This was not the case. Removing
educational level as a confounder in the model and only
adjusting for five confounding factors did not change
the results. Furthermore, for each of the investigated
outcomes, we calculated the correlation between the
estimated coefficients and we found that the highest
correlation between the estimated confounders and psy-
chiatric history was approximately 0.05.
Discussion
A higher cancer stage at the time of the operation for
CC patients but not statistically significantly for RC
patients may most likely points to a delay in the diagno-
sis or in the treatment of CC patients with a pre-existing
serious psychiatric diagnosis, but the reason is unknown
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and may be patient related, or related to the primary
healthcare system or hospital-related factors [35–37].
CC patients with a psychiatric history had a reduced
OR for having received at least one oncological treat-
ment (often as an adjuvant treatment) and oncological
under-treatment of CC patients with a psychiatric his-
tory is possible. The association was present both before
and after adjustment for cancer stage, and was also seen
for each of the two serious psychiatric disorder groups.
In the current Danish and European guidelines for CRC,
psychiatric disorders are not considered a contraindica-
tion for oncological treatment. It is mentioned that
comorbidity in general can change clinical
decision-making, especially in older CRC patients [10–
12]. CRC patients with a psychiatric history are, how-
ever, in average younger than CRC patients without a
psychiatric history. In RC patients, the OR of having had
at least one oncological treatment was also decreased
but however not statistically significantly affected by a
history of psychiatric disorder, where oncological treat-
ment often is given neoadjuvant to the RC operation.
This is to the best of our knowledge the first study to
report differences in oncological treatment due to
pre-existing primary psychotic or affective disorders in
CC patients having an operation, and with the possibility
to adjust for age, gender, comorbidity, and cancer stage.
A study on all patients with a first cancer diagnosis
of all types in 1990–2013 in the Finnish Cancer
Registry, showed excess mortality in people with a
history of psychotic and substance use disorders,
whereas adjusting for cancer treatment decreased the
differences [4]. A study from Australia on all cancers
patients combined and psychiatric disorders from
1988 to 2007 as exposure showed that the psychiatric
patients, especially those with psychoses and depres-
sion, received significantly fewer CRC operations and
had higher all-cause mortality than the general popu-
lation of CRC patients [1]. The study did not look at
oncological treatment for CRC according to the
current guidelines. The reasons and the clinical con-
sequences needed to be investigated further. Possible
explanations for further studies include delays in
symptom recognition or in the initial presentation of
the CC, difficulties in communication, diagnostic de-
lays or other factors in the primary or secondary
healthcare system.
Table 3 The distribution and odds ratio for palliative vs an intended curative aim of the operation among operated colorectal
cancer (CRC) patients, and for oncological treatment for colon and rectum cancer by pre-existing psychiatric history
Study population, (N) -number
with information available
Cancer
procedure
Patients with
psychiatric
disordera
n (%)
Patients without
psychiatric
disordersa
n (%)
Crude OR (95% CI),
(reference no psychiatric
disorder)
Adjusted OR b (95% CI)
(reference no psychiatric
disorder)
Cohort 1
All CRC
(22,010 with information)
Aim of the operative treatmentc
Curative 308 (72.99) 19,392 (78.28)
Palliative 38 (9.00) 2272 (9.17) 1.05 (0.75–1.48) 0.93 (0.62–1.39)
Missing 76 (18.01) 3108 (12.60)
Cohort 2
Colon cancer
(16,641)
Oncological treatmentd
No 193 (64.12) 9519 (58.26)
Yes 108 (35.88) 6821 (41.74) 0.78 (0.62–0.99) 0.55 (0.40–0.76)
Cohort 3
Rectum cancer
(8553)
Oncological treatmentd
No 64 (52.89) 4011 (47.57)
Yes 57 (47.11) 4421 (52.43) 0.81 (0.56–1.16) 0.72 (0.46–1.11)
aPsychiatric disorder cases = having had a history of hospital admission for at least one psychiatric diagnosis as the primary diagnosis according to ICD-10-criteria:
DF20–29: primary psychotic disorders, and DF30–39: affective disorders in the time period from 10 years to 120 days prior to the colorectal cancer operation
bOdds ratio (OR) with 95% confidence interval (CI), adjusted for age, gender, Charlson Comorbidity Index score, cancer stage at the time of operation, educational
level, socio-economic position
cCurative or intended palliative aim of the operative treatment among colon and rectal cancer patients combined regardless of acute or not
dOncological treatment = Received at least one oncological treatment (chemotherapy or radiotherapy), by cancer site
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Strengths and limitations
The strengths of our study were the large Nationwide
Danish study population with close to complete back-
ground information and follow-up from highly valid
registries with prospectively collected patient data thus
minimizing selection bias, comprehensive measures of
potential confounders and nearly complete information
on the chosen diagnoses and treatments for the entire
study population [10, 30].
There may have been a difference in the initial CRC
stage and comorbid disease stages in patients with a
pre-existing psychiatric disorder compared with patients
without a pre-existing psychiatric condition, and espe-
cially among those patients who died within the first
30 days. By only selecting patients, alive at least 30 days
after surgery for the study population may have removed
proportionally more patients with a pre-existing psychi-
atric disorder with a more advanced disease. The finding
of a more advanced disease in the psychiatric group
might thus be underestimated, although we have ad-
justed the analyses for cancer stage as a possible con-
founding factor.
The “treatment” variable had less than 8% missing
values. Still, it is possible with underreporting in this
variable of adjuvant oncological treatment. Since this
rather few missing values of the treatment variable is not
expected to differ between patients with and without
having pre-existing psychiatric disorder, it is not ex-
pected to bias the results [23].
We have included possible confounders previously
mentioned in the CRC literature in the models. Educa-
tional level may to some degree be correlated with
socio-economic position. We checked for each of the
investigated outcomes whether stepwise adjustment for
the possible confounding factors age, gender, Charlson
Comorbidity Index score, cancer stage at the time of op-
eration, socio-economic position, and educational level
had statistically significantly influenced the OR. This was
not the case. Furthermore, the coefficients estimates of
the possible confounding factor socio-economic position
and educational level was only weakly correlated (correl-
ation coefficient approximately 0.05) to the estimate of
psychiatric history. Therefore such correlations may not
explain the findings. Hospital treatments are free of
charge in Denmark and the majority of patients with
symptoms of a severe psychiatric disorder will be re-
ferred at least once to and diagnoses at a public hospital
and thus registered in The National Patient Registry.
However, in Denmark and e.g. Finland a reduction in
psychiatric hospital beds and an increase in out-patient
services have occurred in the recent decades [4] and our
study does not cover patients with e.g. depressive disor-
ders only seen by general practitioners, which may lead
to an underestimation of the associations seen.
Since the psychiatric medication may constitute a
contraindication for oncological treatment for CC, and
oncological treatment requires patient compliance which
can be difficult for patients with psychiatric disorders to
follow, these factors may to some degree explain the
findings [10–12].
Other possible explanations may include the health be-
haviors of the patient, difficulties with regard to commu-
nication, or failures in the primary or secondary
healthcare system for various reasons.
Conclusions
A higher cancer stage at the time of operation point
towards a possible delay in the diagnosis or in the treat-
ment of CC in patients with a serious psychiatric disorder
and these patients also had a decreased OR for receiving
at least one oncological treatment. The reasons for these
differences need to be investigated further e.g. in the
underlying patient records. Attention for CC patients with
serious psychiatric disorders is recommended.
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